Biotechnology (18) | Contribution Agreements (18)

Browse by Company

Centessa Pharmaceuticals Ltd (10 contracts)
Eliem Therapeutics, Inc. (1)
Homology Medicines, Inc. (1)
Medovex Corp. (1)
OncBioMune Pharmaceuticals, Inc (1)
Poseida Therapeutics, Inc. (1)
Sorrento Therapeutics, Inc. (1)
VBI Vaccines Inc (2)

Recent Contracts

Contribution and Satisfaction of Indebtedness Agreement, dated as of September 12, 2022, by and among Sorrento Therapeutics, Inc., Scilex Holding Company and Scilex... (Sorrento Therapeutics, Inc., Filed With SEC on September 14, 2022)
Amendment to the Contribution Agreement, signed March 28, 2022, by and among VBI Vaccines, Inc., Variation Biotechnologies, Inc. and Her Majesty The Queen in Right of Canada as... (VBI Vaccines Inc, Filed With SEC on May 9, 2022)
Contribution Agreement, dated March 10, 2022, between Homology Medicines, Inc. and Roadrunner Solutions LLC (Homology Medicines, Inc., Filed With SEC on March 23, 2022)
Asset Contribution Agreement, dated February 4, 2019, by and between the Registrant and Carnot, LLC (Eliem Therapeutics, Inc., Filed With SEC on July 16, 2021)
Contribution agreement, dated January 23, 2021, by and between Orexia Limited, United Medicines Biopharma Limited and the other parties thereto (Centessa Pharmaceuticals Ltd, Filed With SEC on April 21, 2021)
Contribution Agreement, dated December 31, 2020 (as amended), by and between PearlRiver Bio GmbH, United Medicines Biopharma Limited, and the other parties thereto (Centessa Pharmaceuticals Ltd, Filed With SEC on April 21, 2021)
Contribution Agreement, dated January 23, 2020, by and between Pega-One, United Medicines Biopharma Limited and the other parties thereto (Centessa Pharmaceuticals Ltd, Filed With SEC on April 21, 2021)
Contribution agreement, dated January 23, 2021, by and between Z Factor Limited, United Medicines Biopharma Limited and the other parties thereto (Centessa Pharmaceuticals Ltd, Filed With SEC on April 21, 2021)
Contribution agreement, dated January 23, 2021, by and between Morphogen-IX Limited, United Medicines Biopharma Limited and the other parties thereto (Centessa Pharmaceuticals Ltd, Filed With SEC on April 21, 2021)
Contribution agreement, dated January 23, 2021, by and between LockBody Therapeutics Ltd, United Medicines Biopharma Limited and the other parties thereto (Centessa Pharmaceuticals Ltd, Filed With SEC on April 21, 2021)
Contribution agreement, dated January 23, 2021, by and between Janpix Limited, United Medicines Biopharma Limited and the other parties thereto (Centessa Pharmaceuticals Ltd, Filed With SEC on April 21, 2021)
Contribution agreement, dated January 23, 2021, by and between Inexia Limited, United Medicines Biopharma Limited and the other parties thereto (Centessa Pharmaceuticals Ltd, Filed With SEC on April 21, 2021)
Contribution agreement, dated January 23, 2021, by and between Capella Bioscience LTD, United Medicines Biopharma Limited and the other parties thereto (Centessa Pharmaceuticals Ltd, Filed With SEC on April 21, 2021)
Contribution agreement, dated January 23, 2021, by and between ApcinteX Limited, United Medicines Biopharma Limited and the other parties thereto (Centessa Pharmaceuticals Ltd, Filed With SEC on April 21, 2021)
Contribution Agreement dated April 2, 2021 (Medovex Corp., Filed With SEC on April 8, 2021)
Contribution Agreement, dated September 16, 2020, by and among VBI Vaccines, Inc., Variation Biotechnologies, Inc. and Her Majesty The Queen in Right of Canada as Represented by... (VBI Vaccines Inc, Filed With SEC on November 2, 2020)
Contribution Agreement to the Property of Trust F/2868 entered into among Manuel Cosme Odabachian, Carlos Fernando Alaman Volnie and OncBioMune Pharmaceuticals, Inc. dated March... (OncBioMune Pharmaceuticals, Inc, Filed With SEC on February 21, 2019)
Asset Contribution Agreement, by and between the Registrant and Transposagen Biopharmaceuticals, Inc., dated February 9, 2015 (Poseida Therapeutics, Inc., Filed With SEC on January 4, 2019)